The Election Committee (ELCOM) has carefully selected the following candidate from the nominations, using criteria based on qualifications, experience, and commitment to our Society. We are confident that they possess the necessary skills and expertise to guide EAS towards continued success.
The new member will be replacing the retiring member Prof Christoph Binder (2021-2024) from January 2025. We are pleased to announce the following candidate:
Professor Jeanine Roeters van Lennep
Internist in vascular medicine and associate professor at the department of Internal Medicine, Erasmus MC University, Rotterdam
Biography
Jeanine Roeters van Lennep has been working as internist specialized in vascular medicine at the Erasmus Medical Center, Rotterdam, the Netherlands since 2010.
She is head of the vascular medicine clinic specialized in hereditary dyslipidemia. She combines this research interest with gender-specific medicine.
Her scientific research is dedicated to cardiovascular prevention, specifically diagnosis and treatment of Familial Hypercholesterolemia and sex-specific cardiovascular risk factors such as pre-eclampsia for which she obtained grants of e.g. the Dutch Heart Foundation and the Dutch Research Council.
She is very eager to share her enthusiasm on sex- and gender-specific medicine by organizing educational activities such as the 3-day Gender&Health Course and mentoring junior doctors and researchers.
Jeanine has broad leadership experience as board member of various scientific societies. Currently she is chair of the Dutch Society of Vascular Medicine, chair of the HORIZONSCAN committee of the Dutch National Healthcare Institute to review upcoming cardiovascular drugs, and board member of the Dutch Society of Gender&Health. Moreover she has been chair of the first Dutch Guideline on Dyslipidemia.
She is also involved in the Scandinavian Society of Atherosclerosis Research, an official EAS National Society, for which she organized invited speakers as chairperson in several editions and currently holds the post as financial auditor.
Jeanine is an active member of the EAS. Besides having attended and actively participated in many EAS congresses in the past years, she also organized the very successful Pediatric Familial Hypercholesterolemia Symposium as an official satellite symposium of the 87th EAS congress in 2019.
Vision Statement
As Vice President for the next four years, my goal is to contribute to the EAS’s objectives of advancing and exchanging knowledge, promoting education and training in the prevention and treatment of atherosclerosis and its consequences, and enhancing global awareness of cardiovascular diseases. Furthermore, my personal vision for the EAS involves ensuring diversity and inclusion in its leadership and all activities. Diversity encompasses not only gender and geographical balance but also a balance in career stages.
It is crucial that the EAS consistently attracts and retains talented early-career researchers and clinicians in the field of atherosclerosis/cardiovascular disease research and healthcare. The EAS’s successful 2-year young fellows program provides a unique platform for networking and development for these individuals. Maintaining engagement with this group beyond the program’s duration, such as by rejuvenating EAS committees, is not only appealing to them but also beneficial for the EAS as their input ensures the attractiveness of activities for early career researchers and clinicians.
The EAS has played a commendable role in promoting the significance of sex and gender in cardiovascular research and care through symposia, webinars, and the publication of the EAS call to action “Women, Lipids, and Atherosclerotic Cardiovascular Disease.” While this effort is highly admirable, it is essential that these activities become ingrained in the EAS DNA and are extended to encompass men’s health and other aspects of diversity, ensuring their ongoing impact rather than being temporary initiatives. The EAS has evolved into a truly global society with a workload that requires a dedicated, highly motivated and energetic EC. Throughout my career across various roles, I have always tried to put in a hundred percent to contribute to the wider community, believing that we are at our best when we work together. I hope to continue to support the mission of the EAS as Vice President if elected.
Current positions
(Information on all positions, both within companies and other Societies)
Companies
- None
Other Societies
- 2023-present Board member European Atherosclerosis Society (EAS) consensus panel
- 2022-present Board member Dutch Atherosclerosis Society
- 2021-present Board member Executive Committee European Atherosclerosis Society (EAS)
- 2019-2022 Chair Dutch Society for Internists Vascular Medicine (NVIVG)
- 2017-present Board member Dutch Society of Gender and Health
- 2016-present Chair Dyslipidemia working group Dutch Society for Internists Vascular Medicine (NVIVG)
- 2022-present Scientific Advisory Board FH Europe
- 2020-present Advisory Board LEEFH (National Expert Centre for Hereditary Dyslipidemia)
- 2020-present Scientific Advisory Board Dutch Heart Foundation
- 2014- 2020 Scientific Advisory Board LEEFH (National Expert Centre for Hereditary Dyslipidemia)
- 2022-present Chair Dekker committee (clinical scientist/post doc fellowship) Dutch Heart Foundation
- 2019- present Review board Fellowship Gender & Research (ZonMW)
- 2019-present Review board Corrie Hermann Prize (VNVA Dutch Society of Female Physicians)
- 2018- present Review board European Science Foundation
Maintaining Integrity in EAS Scientific and Clinical Activities
EAS manages conflicts of interest to maintain integrity in scientific and clinical activities organized by its members. This includes guidelines, consensus papers, journals, congresses, and educational content. Please see the complete disclosure of potential conflicts of interest below.
You have to be full member and logged in to view Faculty Conflict of Interest Disclosures